New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.

In women with a history of spontaneous preterm birth, a cervical length > 25-30 mm during the midtrimester is linked to higher odds of recurrent spontaneous preterm birth.

The new compound called Rytvela prevents preterm birth and organ damage in animal studies by stopping inflammation, whereas the common drug nifedipine failed.

Women with a history of successfully treated preterm labour who delivered at term faced a higher risk for preterm birth during the subsequent pregnancy than those who delivered at term without any ...

Imagine if you could predict which mothers would give birth prematurely. Then imagine there was some easy interventions to prevent that. A new national study of more than 5,000 pregnant women in 19 ...